However, the loss is typically focal and does not exceed 5% of the entire specimen [26,31,33], except in cases of endometrial polyps, where approximately 10–20% of cases show more widespread PAX2 loss [47,48]. This evidence concerns the gene PAX2 and endometrial polyp.